M&A and Fundraising Analysis for October 8, 2026

Trasteel finalizes full control of BBC Alloys: vertical integration in ferroalloys

Source: markets.businessinsider.com → · Sector Industrial Tech & Manufacturing — 📬 subscribe to the Industrial Tech & Manufacturing newsletter

Trasteel Holding, a Swiss steel trading and industrial group, acquires the remaining 40% of BBC Alloys S.r.l. held by Metco S.r.l., making BBC Alloys a 100% subsidiary.

BBC Alloys, based in Milan with a logistics hub in Tortona, trades, processes, and distributes ferroalloys—essential raw materials for steel manufacturing—to steel mills and foundries in Italy and Europe. Trasteel already held 60% since June 2025 and had begun integration. BBC Alloys generated €89 million in revenue in 2025 (+8.7% year-on-year) and €63.9 million in the first half of 2026 (+30% compared to the first half of 2025).

This is a logical closing operation: as BBC Alloys has already been consolidated in Trasteel's accounts since June 2025, the transaction eliminates the minority interest and simplifies governance. The acceleration of BBC Alloys' growth since Trasteel's entry—+30% in the first half of 2026—suggests that sourcing, logistics, and financing synergies played out quickly. The acquisition of the remainder validates the initial thesis.

G Square acquires Valtecne and delists it: a medical precision specialist absorbed

G Square Healthcare Private Equity acquires approximately 82% of the capital of Valtecne S.p.A., an Italian manufacturer of high-precision mechanical components for the medical device (MedTech) sector, from the Mainetti family. The operation will result in the delisting from Euronext Growth Milan.

Valtecne manufactures components and assembled devices for international clients in highly regulated sectors. GLAS acted as issuing agent, calculation agent, and security agent in connection with the acquisition financing; Muzinich & Co. acted as lender in the private debt. A mandatory public offer will be launched to enable full delisting.

Strategic interpretation: G Square, a fund specializing in healthcare, is consolidating a position in precision subcontracting for MedTech—a segment that structurally benefits from demographic aging and the increasing complexity of implantable medical devices. The delisting signals that G Square prefers to drive the transformation away from the quarterly pressure of public markets—classic for a transformational LBO over a medium horizon.

Arcus Infrastructure acquires SK Pharma Logistics: German pharmaceutical logistics becomes infrastructure-owned

Source: investorsinhealthcare.com → · Sector Developer & IT Infrastructure — 📬 subscribe to the Developer & IT Infrastructure newsletter

Arcus Infrastructure Partners, a British infrastructure fund, acquires SK Pharma Logistics, an independent German specialized logistics provider for the pharmaceutical and healthcare industry, from Syz Capital, Saturnus Capital, and founder Stefan Krone. The management team reinvests alongside Arcus.

Founded in 2003 and based in Northwest Germany, SK Pharma operates eight warehouses representing approximately 85,000 m² of temperature-controlled storage capacity, with over 100,000 pallet positions. It provides GDP/GMP warehousing, distribution, and value-added logistics services to pharmaceutical manufacturers, importers, and wholesalers. Its revenue increased from €48 million in 2021 to €74 million in 2025 under previous management.

What is notable here is the acquirer's positioning: Arcus is an infrastructure fund, not a generalist private equity fund. Treating temperature-controlled pharmaceutical logistics as infrastructure—an asset with high regulatory barriers, predictable flows, captive clients—is a framing that reflects the sector's maturation. For an investor seeking defensive real assets in Europe, specialized healthcare logistics increasingly resembles critical infrastructure.